These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6685632)

  • 1. A comparative study of electrophoretic mobilities of [3H]-estradiol and monohydroxytamoxifen binding components in the cytosols of human breast carcinomas and sera of healthy adult females.
    Raam S; D'Agincourt PG; Jordan VC
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1457-65. PubMed ID: 6685632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor.
    Tate AC; Greene GL; DeSombre ER; Jensen EV; Jordan VC
    Cancer Res; 1984 Mar; 44(3):1012-8. PubMed ID: 6692388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of [3H] estradiol - and [3H] monohydroxytamoxifen-estrogen receptor complexes with a monoclonal antibody.
    Tate AC; DeSombre ER; Greene GL; Jensen EV; Jordan VC
    Breast Cancer Res Treat; 1983; 3(3):267-77. PubMed ID: 6671136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding sites of droloxifene in the cytosol of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor cells.
    Kawamura I; Lacey E; Tanaka Y; Nishigaki F; Manda T; Shimomura K
    Jpn J Cancer Res; 1994 Jun; 85(6):639-44. PubMed ID: 8063618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical and genetic evidence for specific antiestrogen binding sites.
    Faye JC; Jozan S; Redeuilh G; Baulieu EE; Bayard F
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3158-62. PubMed ID: 6574477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The two native estrogen receptor forms of 8S and 4S present in cytosol from human uterine tissues display opposite reactivities with the antiestrogen tamoxifen aziridine and the estrogen responsive element.
    Navarro D; León L; Chirino R; Fernández L; Pestano J; Díaz-Chico BN
    J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):49-58. PubMed ID: 9569010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B; Happe HK
    Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pure antiestrogen ICI 182,780 binds to a high-affinity site distinct from the estrogen receptor.
    Parisot JP; Hu XF; Sutherland RL; Wakeling A; Zalcberg JR; DeLuise M
    Int J Cancer; 1995 Aug; 62(4):480-4. PubMed ID: 7635575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiestrogen binding sites in human breast cancer biopsies. Measurement ligand-specificity and affinity, and correlation to estrogen and progesterone receptors.
    Fernö M; Borg A
    Anticancer Res; 1985; 5(3):307-12. PubMed ID: 4015045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen aziridine binding to cytosolic proteins from human breast specimens is negatively associated with estrogen receptors, progesterone receptors, pS2, and cathepsin-D.
    Navarro D; Doreste H; Cabrera JJ; Morales M; Díaz-Chico JC; Díaz-Chico BN
    Breast Cancer Res Treat; 1998 Jul; 50(2):155-66. PubMed ID: 9822220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of estrogen and antiestrogen binding to the cytosol and microsomes of breast tumors.
    Lopes MC; Tavares MC; Vale MG; Carvalho AP
    J Steroid Biochem Mol Biol; 1991 Sep; 39(3):343-52. PubMed ID: 1911424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocation of cytoplasmic estrogen receptors to the nucleus: immunohistochemical demonstration utilizing rabbit antibodies to estrogen receptors of mammary carcinomas.
    Raam S; Richardson GS; Bradley F; MacLaughlin D; Sun L; Frankel F; Cohen JL
    Breast Cancer Res Treat; 1983; 3(2):179-99. PubMed ID: 6351951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells.
    Borrás M; Laios I; el Khissiin A; Seo HS; Lempereur F; Legros N; Leclercq G
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):203-13. PubMed ID: 8645630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiestrogenic activity of DP-TAT-59, an active metabolite of TAT-59 against human breast cancer.
    Toko T; Shibata J; Nukatsuka M; Yamada Y
    Cancer Chemother Pharmacol; 1997; 39(5):390-8. PubMed ID: 9054952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA.
    Klinge CM; Traish AM; Bambara RA; Hilf R
    J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):51-66. PubMed ID: 8645617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential impact of flanking sequences on estradiol- vs 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA.
    Anolik JH; Klinge CM; Bambara RA; Hilf R
    J Steroid Biochem Mol Biol; 1993 Dec; 46(6):713-30. PubMed ID: 8274405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of [3H] monohydroxytamoxifen in ovarian carcinoma.
    Holt JA; Jordan VC; Tate AC; Lorincz MA
    Br J Obstet Gynaecol; 1983 Aug; 90(8):751-8. PubMed ID: 6882707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of tritiated estradiol and tamoxifen aziridine for measurement of estrogen receptors in human breast cancer cytosols.
    Piccart MJ; Muquardt C; Bosman C; Pirotte P; Veenstra S; Grillo F; Leclercq G
    J Natl Cancer Inst; 1991 Nov; 83(21):1553-9. PubMed ID: 1960752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.